Up a level |
(2022) Initial preclinical evaluation of 68Ga-DOTA-(Ser)3-LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging. Nuclear Medicine Communications. pp. 945-951.
(2022) Initial preclinical evaluation of <SUP>68</SUP>Ga-DOTA-(Ser)<sub>3</sub>-LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging. Nuclear Medicine Communications. pp. 945-951. ISSN 0143-3636